Similarly, the fusion partner ELK4 is up-regulated in tumor samples expressing the SLC45A3-ELK4 fusion in comparison with fusion-negative tumor samples (p = 0.01) and benign samples (p = 6.3E-05, Wilcoxon rank-test; Figure 3B). The gene discussed is ELK4; the disease is neoplasm.